GlucoTrack
GCTK
8 hedge funds and large institutions have $103K invested in GlucoTrack in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
100% more funds holding
Funds holding: 4 → 8 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
23% less capital invested
Capital invested by funds: $133K → $103K (-$30.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$90.2K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$90.2K |
| 3 |
Renaissance Technologies
New York
|
+$25.4K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$17.8K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $42.1K | +$90.2K | +71 | +309% |
|
|
XT
2
XTX Topco
George Town,
Cayman Islands
| $31.9K | +$90.2K | +71 | New |
|
|
3
Renaissance Technologies
New York
| $8.96K | +$25.4K | +20 | New |
|
|
4
Cetera Investment Advisers
Schaumburg,
Illinois
| $7.46K | +$11.4K | +9 | +113% |
|
|
5
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $6.13K | +$17.8K | +14 | New |
|
|
AF
6
Alerus Financial
Grand Forks,
North Dakota
| $5.17K | – | – | – |
|
7
Morgan Stanley
New York
| $485 | +$1.27K | +1 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $403 | +$1.27K | +1 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $12 | – | – | – |
|
|
SS
10
SBI Securities
Tokyo,
Japan
| $3 | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$7.43K | -3 | Closed |
|
GCTK Hedge Fund Activity: Q4 2024 in Review
8 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q4 2024, worth a combined $103K — down 23% from $133K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GCTK positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $90.2K. The largest seller was UBS Group, exiting entirely with an estimated $7.43K sold.
- 8 institutional investors held GlucoTrack (GCTK) as of Q4 2024, up from 4 in Q3 2024.
- Funds reported $103K of GlucoTrack stock for Q4 2024, down 23% quarter-over-quarter.
- 5 funds opened new GlucoTrack positions in Q4 2024 and 1 closed out, a net change of +4 holders.
- The largest GlucoTrack buyer in Q4 2024 was Geode Capital Management, an estimated $90.2K added.
- The largest GlucoTrack seller in Q4 2024 was UBS Group, an estimated $7.43K sold.
Based on aggregated 13F filings for Q4 2024.